{"id":"W3193211635","doi":"10.1097/hs9.0000000000000617","title":"Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Clinical endpoint; Myeloid leukemia; Randomized controlled trial; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196189,0.0009488171,0.001824215,0.0002381586,0.0002592089,0.0008077895,0.0005753691,0.001004605,0.003960534],"category_scores_gemma":[0.0009596011,0.0002700507,0.001480919,0.0003283557,0.0006123979,0.0006361757,0.0003082043,0.002630014,0.0006975503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004667041,"about_ca_system_score_gemma":0.0008557739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003254386,"about_ca_topic_score_gemma":0.001123331,"domain_scores_codex":[0.9996939,0.0001743171,0.00001572033,0.00004707084,0.00002653916,0.00004247883],"domain_scores_gemma":[0.9994949,0.0001277535,0.0001370741,0.00004238751,0.00002816299,0.0001698031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9015991,0.01097578,0.001416391,0.001327802,0.001262077,0.0001543921,0.0001097425,0.001079871,0.008337295,0.0003806755,0.002910379,0.07044651],"study_design_scores_gemma":[0.9081109,0.08602339,0.002230761,0.0000550526,0.0002972606,0.0001293659,0.00002356184,0.000668306,0.0004826607,0.0003169657,0.001648497,0.00001326876],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832339,0.008371958,0.0008260607,0.0009372043,0.0004780569,0.002746202,0.0008170275,0.00017455,0.002415071],"genre_scores_gemma":[0.9801602,0.005741423,0.002460868,0.001874955,0.0004445668,0.004794574,0.001739934,0.00002847351,0.002754905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003960534,"threshold_uncertainty_score":0.01324928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02104062024741899,"score_gpt":0.311902993568538,"score_spread":0.290862373321119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}